Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A description of the coagulopathy characteristics in amniotic fluid embolism: a case report.

International journal of obstetric anesthesia·2022
Same author

The sensitivity and specificity of rotational thromboelastometry (ROTEM) to detect coagulopathy during moderate and severe postpartum haemorrhage: a prospective observational study.

International journal of obstetric anesthesia·2021
Same author

Experience of immune tolerance in a carrier of severe haemophilia A with inhibitor development post-surgery.

Haemophilia : the official journal of the World Federation of Hemophilia·2017
Same author

Carrier detection and prenatal diagnosis by intron 22 inversion analysis of the factor VIII gene.

Haemophilia : the official journal of the World Federation of Hemophilia·2016
Same author

X-linked moyamoya syndrome associated with severe haemophilia A.

Haemophilia : the official journal of the World Federation of Hemophilia·2015
Same author

Age-related factor IX correction in symptomatic female carriers with haemophilia B Leyden.

Haemophilia : the official journal of the World Federation of Hemophilia·2015

Related Experiment Video

Updated: Jun 4, 2026

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
08:30

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation

Published on: August 14, 2017

Screening for Candidate Mutations Causing von Willebrand's Disease (vWD).

P V Jenkins1

  • 1Department of Haematology, Haemophilia Centre and Haemostasis Unit, Royal Free Hospital School of Medicine, London, UK.

Methods in Molecular Medicine
|February 23, 2011
PubMed
Summary

Von Willebrand factor (vWF) is crucial for blood clotting, aiding platelet adhesion and stabilizing factor VIII. Its complex structure, with specific domains, dictates its diverse functions in hemostasis.

More Related Videos

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations
10:41

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations

Published on: March 29, 2017

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation
07:17

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation

Published on: August 23, 2024

Related Experiment Videos

Last Updated: Jun 4, 2026

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
08:30

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation

Published on: August 14, 2017

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations
10:41

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations

Published on: March 29, 2017

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation
07:17

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation

Published on: August 23, 2024

Area of Science:

  • Biochemistry
  • Hematology
  • Molecular Biology

Background:

  • Von Willebrand factor (vWF) is a large glycoprotein essential for hemostasis, found in plasma and platelets.
  • vWF is synthesized by megakaryocytes and endothelial cells, playing a dual role in platelet adhesion and factor VIII stabilization.
  • Its function is intrinsically linked to its complex multidomain structure.

Purpose of the Study:

  • To elucidate the structure-function relationships of von Willebrand factor (vWF).
  • To detail the specific roles of different vWF domains in hemostasis.
  • To understand the molecular mechanisms underlying vWF's interactions in blood clotting.

Main Methods:

  • Analysis of the multidomain structure of vWF.
  • Identification of functional domains responsible for specific molecular interactions.
  • Characterization of post-translational modifications including dimerization and multimerization.

Main Results:

  • vWF comprises multiple domain types (A-D) in a specific arrangement.
  • Post-translational processing yields dimeric and multimeric forms of vWF.
  • Specific domains are responsible for distinct functions: A1 (platelet GpIb, collagen, heparin binding), D3 (factor VIII binding), C2 (platelet GpIIb-IIIa binding), and A3 (collagen type III binding).

Conclusions:

  • The multidomain structure of vWF is critical for its diverse functions in hemostasis.
  • Each domain within vWF is specialized for specific molecular interactions, including platelet aggregation and factor VIII transport.
  • Understanding these domain-specific functions provides insight into the molecular basis of hemostasis and bleeding disorders.